title: Ligand-specific selection of MHC class II-restricted thymocytes in fetal thymic organ culture.
abstract: Positive and negative selection of thymocytes is determined by the specificity of the TCR and signaling through its associated molecules. We have studied selection of thymocytes bearing a MHC class II-restricted TCR using fetal thymic organ culture. This system allows the addition of peptides to the already diverse panoply of endogenous peptide ligands and is useful for analyzing ligand-specific negative selection of CD4 single positive (CD4SP) thymocytes. The data reveal that the ability of a given ligand to mediate negative selection is related to its dissociation rate from the TCR. We find that negative selection is very sensitive, and only the weakest ligand that we can identify fails to induce negative selection. None of the numerous peptides tested were able to induce an increase in CD4SP thymocytes. In addition, the ligands that induce negative selection of CD4SP thymocytes also cause an increase in numbers of CD8SP thymocytes bearing high levels of the class II-restricted TCR. Although these cells have a cell surface phenotype consistent with positive selection, they most likely represent cells in the process of negative selection. Further analysis reveals that these cells are not induced by these ligands in intact adult animals and that their induction is probably only revealed in the organ culture system.
authors.affiliation: Department of Pathology and Center for Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
authors.forename: G J
authors.initials: GJ
authors.lastname: Kersh
authors.forename: D L
authors.initials: DL
authors.lastname: Engle
authors.forename: C B
authors.initials: CB
authors.lastname: Williams
authors.forename: P M
authors.initials: PM
authors.lastname: Allen
mesh_terms: D019943:Amino Acid Substitution / Q000276:immunology; D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D018984:Epitopes, T-Lymphocyte / Q000276:immunology / Q000378:metabolism*; D005333:Fetus; D006454:Hemoglobins / Q000276:immunology / Q000378:metabolism; D000949:Histocompatibility Antigens Class II / Q000276:immunology / Q000378:metabolism*; D008024:Ligands; D008213:Lymphocyte Activation; D051379:Mice; D008806:Mice, Inbred AKR; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009842:Oligopeptides / Q000819:agonists / Q000276:immunology / Q000378:metabolism; D009924:Organ Culture Techniques; D011948:Receptors, Antigen, T-Cell / Q000819:agonists / Q000378:metabolism; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000378:metabolism*; D013950:Thymus Gland / Q000166:cytology / Q000276:immunology* / Q000378:metabolism*
chemical_list: D018984:Epitopes, T-Lymphocyte; D006454:Hemoglobins; D000949:Histocompatibility Antigens Class II; C024138:I-E-antigen; D008024:Ligands; D009842:Oligopeptides; D011948:Receptors, Antigen, T-Cell